The Scientist - Home

With complicated lifecycles and genetics, parasitic worms can be hard to study, but organoids unveil new insight into their biology and a path to better drugs.

Gut bacteria bioaccumulated so-called forever chemicals, leading to new insights on how PFAS affects biology and paths to bioremediation.

The academic system prioritizes publications and grants over real-world impact; researchers now advocate for a shift to value collaboration and translational discoveries.

Triple-negative breast cancer cells build bridges to activate adipocytes and fuel themselves, highlighting a target for future therapies.

How can neurons respond to optical stimulation without genetic or structural alterations? Turns out that a thin-layer carbon sheet might do the trick.

Sugars, amino acids, and fatty acids activate distinct subsets of intestinal neurons, revealing how the gut responds to different food components.

Organoids generated from tonsils removed during surgeries provide a reliable in vitro platform to study human immune responses.

Some lipids may protect against excessive daytime sleepiness, a metabolomics study that involved thousands of people around the world suggests. 

A noninvasive approach to correcting misshapen eyeballs could expand treatment options for people with vision problems where LASIK is out of reach.

There is no cure for congenital erythropoietic porphyria, but after years of work and patient collaboration, a potential drug is on the brink of approval.

Dysregulated lipid metabolism in Alzheimer’s disease causes lipid buildup in microglia, reducing the immune cell’s ability to clear amyloid beta plaques.

Hunger doesn’t just rumble in the stomach; it sparks changes in the brain’s emotional circuits.